Spinifex Pharmaceuticals
Clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
Launch date
Employees
Market cap
-
Enterprise valuation
€182m (Public information from Jun 2015)
Stamford Connecticut (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
AUD3.3m | Series A | ||
* | AUD12.0m | Series A | |
$19.0m | Series B | ||
$45.0m | Series C | ||
$200m Valuation: $200m | Acquisition | ||
Total Funding | €67.2m |